IRHYTHM HOLDINGS INC (IRTC) Fundamental Analysis & Valuation

NASDAQ:IRTC • US4500561067

Current stock price

116.28 USD
-1.5 (-1.27%)
At close:
116.28 USD
0 (0%)
After Hours:

This IRTC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. IRTC Profitability Analysis

1.1 Basic Checks

  • IRTC had negative earnings in the past year.
  • In the past year IRTC had a positive cash flow from operations.
  • In the past 5 years IRTC always reported negative net income.
  • In multiple years IRTC reported negative operating cash flow during the last 5 years.
IRTC Yearly Net Income VS EBIT VS OCF VS FCFIRTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M -100M

1.2 Ratios

  • The Return On Assets of IRTC (-4.37%) is better than 69.02% of its industry peers.
  • Looking at the Return On Equity, with a value of -29.17%, IRTC is in line with its industry, outperforming 53.26% of the companies in the same industry.
Industry RankSector Rank
ROA -4.37%
ROE -29.17%
ROIC N/A
ROA(3y)-15.01%
ROA(5y)-18.57%
ROE(3y)-70.84%
ROE(5y)-59.45%
ROIC(3y)N/A
ROIC(5y)N/A
IRTC Yearly ROA, ROE, ROICIRTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80 -100

1.3 Margins

  • Looking at the Gross Margin, with a value of 70.57%, IRTC is in the better half of the industry, outperforming 79.89% of the companies in the same industry.
  • IRTC's Gross Margin has been stable in the last couple of years.
  • The Profit Margin and Operating Margin are not available for IRTC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-0.81%
IRTC Yearly Profit, Operating, Gross MarginsIRTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. IRTC Health Analysis

2.1 Basic Checks

  • IRTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for IRTC has been increased compared to 1 year ago.
  • IRTC has more shares outstanding than it did 5 years ago.
  • IRTC has a better debt/assets ratio than last year.
IRTC Yearly Shares OutstandingIRTC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
IRTC Yearly Total Debt VS Total AssetsIRTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • IRTC has an Altman-Z score of 2.76. This is not the best score and indicates that IRTC is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a decent Altman-Z score value of 2.76, IRTC is doing good in the industry, outperforming 67.39% of the companies in the same industry.
  • IRTC has a debt to FCF ratio of 18.81. This is a negative value and a sign of low solvency as IRTC would need 18.81 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 18.81, IRTC is doing good in the industry, outperforming 70.11% of the companies in the same industry.
  • IRTC has a Debt/Equity ratio of 4.25. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of IRTC (4.25) is worse than 85.87% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 18.81
Altman-Z 2.76
ROIC/WACCN/A
WACC9.63%
IRTC Yearly LT Debt VS Equity VS FCFIRTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

2.3 Liquidity

  • IRTC has a Current Ratio of 4.63. This indicates that IRTC is financially healthy and has no problem in meeting its short term obligations.
  • IRTC has a Current ratio of 4.63. This is in the better half of the industry: IRTC outperforms 71.74% of its industry peers.
  • IRTC has a Quick Ratio of 4.48. This indicates that IRTC is financially healthy and has no problem in meeting its short term obligations.
  • IRTC has a better Quick ratio (4.48) than 76.63% of its industry peers.
Industry RankSector Rank
Current Ratio 4.63
Quick Ratio 4.48
IRTC Yearly Current Assets VS Current LiabilitesIRTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. IRTC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.34% over the past year.
  • Looking at the last year, IRTC shows a very strong growth in Revenue. The Revenue has grown by 26.24%.
  • Measured over the past years, IRTC shows a very strong growth in Revenue. The Revenue has been growing by 23.02% on average per year.
EPS 1Y (TTM)66.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2800%
Revenue 1Y (TTM)26.24%
Revenue growth 3Y22.05%
Revenue growth 5Y23.02%
Sales Q2Q%27.12%

3.2 Future

  • IRTC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.06% yearly.
  • Based on estimates for the next years, IRTC will show a quite strong growth in Revenue. The Revenue will grow by 16.75% on average per year.
EPS Next Y74.01%
EPS Next 2Y65.6%
EPS Next 3Y52.66%
EPS Next 5Y47.06%
Revenue Next Year18.41%
Revenue Next 2Y17.17%
Revenue Next 3Y16.63%
Revenue Next 5Y16.75%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
IRTC Yearly Revenue VS EstimatesIRTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B
IRTC Yearly EPS VS EstimatesIRTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2

More info and screens

Find the best growth stocksShow best growing peers

2

4. IRTC Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IRTC. In the last year negative earnings were reported.
  • Also next year IRTC is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IRTC Price Earnings VS Forward Price EarningsIRTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300 -400

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of IRTC indicates a somewhat cheap valuation: IRTC is cheaper than 69.57% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 108.87
EV/EBITDA N/A
IRTC Per share dataIRTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IRTC's earnings are expected to grow with 52.66% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y65.6%
EPS Next 3Y52.66%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IRTC Dividend Analysis

5.1 Amount

  • IRTC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IRTC Fundamentals: All Metrics, Ratios and Statistics

IRHYTHM HOLDINGS INC

NASDAQ:IRTC (3/20/2026, 8:02:10 PM)

After market: 116.28 0 (0%)

116.28

-1.5 (-1.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-19
Earnings (Next)04-29
Inst Owners110.26%
Inst Owner Change-35.93%
Ins Owners1.29%
Ins Owner Change1.29%
Market Cap3.76B
Revenue(TTM)747.14M
Net Income(TTM)-44.55M
Analysts86.36
Price Target216.97 (86.59%)
Short Float %10.74%
Short Ratio4.73
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)408.63%
Min EPS beat(2)81.05%
Max EPS beat(2)736.22%
EPS beat(4)4
Avg EPS beat(4)214.01%
Min EPS beat(4)4.68%
Max EPS beat(4)736.22%
EPS beat(8)6
Avg EPS beat(8)106.43%
EPS beat(12)7
Avg EPS beat(12)59.14%
EPS beat(16)10
Avg EPS beat(16)48.17%
Revenue beat(2)2
Avg Revenue beat(2)1.97%
Min Revenue beat(2)1.59%
Max Revenue beat(2)2.36%
Revenue beat(4)4
Avg Revenue beat(4)2.65%
Min Revenue beat(4)1.42%
Max Revenue beat(4)5.22%
Revenue beat(8)6
Avg Revenue beat(8)1.4%
Revenue beat(12)8
Avg Revenue beat(12)1.15%
Revenue beat(16)10
Avg Revenue beat(16)0.88%
PT rev (1m)-3.4%
PT rev (3m)-3.57%
EPS NQ rev (1m)-42.08%
EPS NQ rev (3m)-44.54%
EPS NY rev (1m)15.61%
EPS NY rev (3m)16.49%
Revenue NQ rev (1m)1.3%
Revenue NQ rev (3m)1.38%
Revenue NY rev (1m)1.12%
Revenue NY rev (3m)1.53%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.03
P/FCF 108.87
P/OCF 46.48
P/B 24.6
P/tB 24.74
EV/EBITDA N/A
EPS(TTM)-1.04
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)1.07
FCFY0.92%
OCF(TTM)2.5
OCFY2.15%
SpS23.12
BVpS4.73
TBVpS4.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.37%
ROE -29.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.57%
FCFM 4.62%
ROA(3y)-15.01%
ROA(5y)-18.57%
ROE(3y)-70.84%
ROE(5y)-59.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y-0.81%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 18.81
Debt/EBITDA N/A
Cap/Depr 223.42%
Cap/Sales 6.2%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.63
Quick Ratio 4.48
Altman-Z 2.76
F-Score6
WACC9.63%
ROIC/WACCN/A
Cap/Depr(3y)235.65%
Cap/Depr(5y)242.93%
Cap/Sales(3y)7.56%
Cap/Sales(5y)7.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2800%
EPS Next Y74.01%
EPS Next 2Y65.6%
EPS Next 3Y52.66%
EPS Next 5Y47.06%
Revenue 1Y (TTM)26.24%
Revenue growth 3Y22.05%
Revenue growth 5Y23.02%
Sales Q2Q%27.12%
Revenue Next Year18.41%
Revenue Next 2Y17.17%
Revenue Next 3Y16.63%
Revenue Next 5Y16.75%
EBIT growth 1Y35.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year289.67%
EBIT Next 3Y76.44%
EBIT Next 5Y60.06%
FCF growth 1Y175.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2285.34%
OCF growth 3YN/A
OCF growth 5YN/A

IRHYTHM HOLDINGS INC / IRTC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IRHYTHM HOLDINGS INC (IRTC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to IRTC.


Can you provide the valuation status for IRHYTHM HOLDINGS INC?

ChartMill assigns a valuation rating of 2 / 10 to IRHYTHM HOLDINGS INC (IRTC). This can be considered as Overvalued.


What is the profitability of IRTC stock?

IRHYTHM HOLDINGS INC (IRTC) has a profitability rating of 2 / 10.


What is the expected EPS growth for IRHYTHM HOLDINGS INC (IRTC) stock?

The Earnings per Share (EPS) of IRHYTHM HOLDINGS INC (IRTC) is expected to grow by 74.01% in the next year.